Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Novacyt   /   Novacyt de volgende biotech raket!

Aandeel Novacyt PSE:ALNOV.FR, FR0010397232

Laatste koers (eur) Verschil Volume
0,602   -0,023   (-3,68%) Dagrange 0,590 - 0,632 199.670   Gem. (3M) 1M

Novacyt de volgende biotech raket!

Volgen
70.763 Posts
Pagina: «« 1 ... 2332 2333 2334 2335 2336 ... 3539 »» | Laatste | Omlaag ↓
  15. Cum infamia 16 januari 2021 03:11

    U.S. Food and Drug Administration
    Testing updates:
    As of January 15, 317 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 236 molecular tests and sample collection devices, 68 antibody tests, and 13 antigen tests. There are 32 molecular authorizations that can be used with home-collected samples. There is one molecular prescription at-home test, one antigen prescription at-home test, and one over-the-counter (OTC) at-home antigen test.
  17. [verwijderd] 16 januari 2021 08:57
    Results
    Using isolated RNA variplex™?RT-LAMP showed a sensitivity of 75 % compared to LightMix?E gene RT-PCR but contrary to the latter it produced no false-positive results. For the evaluation of samples from respiratory secretions concordance analysis showed only a moderate agreement between the variplex™?RT-LAMP conducted on unprocessed samples and Allplex™?and VIASURE RT-PCRs (Cohen’s ??ranging from 0.52-0.56). Using the approach to define a sample as true-positive when at least two assays gave a positive result the clinical sensitivities were as follows: 76.3 % for variplex™, 84.2 % for Allplex™?and 68.4 % for VIASURE. However, when results of RT-PCR and RT-LAMP were combined diagnostic sensitivity was increased to 92–100 %.

    Conclusion
    The variplex RT-LAMP may serve as a rapid test to be combined with a RT-PCR assay to increase the diagnostic accuracy in patients with suspected COVID-19 infection.

    www.sciencedirect.com/science/article...

  19. forum rang 5 Louis7 16 januari 2021 09:35

    Novacyt COVID-19 Diagnostic tests remain able to detect all published virus strains.
    January 14, 2021

    AFSBio is proud to partner with Novacyt Group/Primer Design for North America to offer their SaRS-COV-2 (FDA/EUA approved) and SaRS-COV2 Winterplex assays. Both CE-IVD certified.

    They test for both ORF1ab and the S gene with 100% specificity. The Winterplex assay also includes Influenza A, B, and RSV.

    Their latest press release shows that both tests can still detect the new COVID-19 variant by the UK's COVID-19 Genomics UK consortium, known as VUI-202012/01 with the same high level of accuracy.

    Novacyt notes this new strain of the virus has also been identified in other countries, including the Netherlands, Denmark, and Australia.

    afsbio.com/blogs/news/novacyt-covid-1...
70.763 Posts
Pagina: «« 1 ... 2332 2333 2334 2335 2336 ... 3539 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

Benieuwd naar onze analyses en kooptips?

Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!

Word abonnee